MedPlus Health Services shares surged more than 4% in Monday’s trade after the company reported strong financial performance for the September quarter (Q2 FY26). The upbeat earnings were driven by steady revenue growth and a sharp jump in profitability.
For the quarter ended September 2025, MedPlus reported a 6.5% year-on-year rise in revenue to ₹1,679 crore, compared to ₹1,576 crore in the same period last year. The company’s EBITDA climbed 19.6% to ₹149 crore, while margins improved to 8.9% from 7.9%, reflecting better cost control and operating efficiency.
Net profit also saw a healthy boost, rising 43.4% to ₹55.5 crore, against ₹38.7 crore a year ago.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
